Beryl Drugs board to meet November 13 for financial results

Beryl Drugs Limited announced that its board of directors will convene a meeting on Thursday, November 13, 2025, at 02:00 PM. The meeting is scheduled to take place at the company's registered office located at 133, Kanchan Bagh, Indore 452001 MP.

The primary agenda items for the board meeting include the consideration and approval of the unaudited financial results for the quarter and half-year ended September 30, 2025. Additionally, the board will review and take on record the limited review report pertaining to the same period. Any other resolutions, with the chair's permission, may also be discussed.

This announcement, dated November 5, 2025, was issued by Sudhir Sethi, chairman & director of Beryl Drugs Limited. The company's BSE Code is 524606.